GuidelineArchives of gynecology and obstetrics2025

Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer.

Lukas Chinczewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.